Conference
Earn CE
Free Samples
Magazine
Subscribe
Videos
Solutions Lab
Macro/Op-Ed
Practice
Science & Tech
Money
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Dental Market Index
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about MDMA/assisted therapy
Recent news which mentions MDMA/assisted therapy
Multidisciplinary Association For Psychedelic Studies Funds MDMA-Assisted Therapy Trial For PTSD
August 29, 2024
Tickers
MDMA
NEWS
Tags
Jessica Maples/Keller
News
Massed Prolonged Exposure Therapy
From
Benzinga
Lykos Therapeutics Strategic Reorganization Following FDA's Decision Rejecting MDMA For PTSD Treatment
August 16, 2024
Tickers
NEWS
Tags
News
Multidisciplinary Association for Psychedelic Studies (MAPS)
Amy Emerson
From
Benzinga
MDMA Therapy Papers Retracted Amid Ethical Concerns At Lykos Study Site
August 13, 2024
Tags
Multidisciplinary Association for Psychedelic Studies (MAPS)
Psychedelics
Benzinga
From
Benzinga
Five Out Of Six Studies On MDMA Show Positive Results, Yet FDA Approval Still Faces Hurdles
August 07, 2024
Tickers
NEWS
Tags
FDA
PTSD
Psychedelics
From
Benzinga
Art Installation Near White House Urges FDA To Approve MDMA-Assisted Therapy For Veterans As Decision Time Looms
July 29, 2024
Tickers
NEWS
Tags
Health Care
PTSD in veterans
Top Stories
From
Benzinga
Two Top Biotechs Forge MDMA Supply Deals For Clinical Research
March 26, 2024
Tickers
MDXXF
NEWS
NUMIF
OPTHF
Tags
Addiction Treatment
MDXXF
Management
From
Benzinga
Atai Life Sciences Shows Positive Results In Phase 1 Clinical Study For PTSD Treatment
January 04, 2024
Tickers
ATAI
NEWS
Tags
Psychedelic/Assisted Therapies
R/MDMA
Biotech
From
Benzinga
Could MDMA Revolutionize PTSD Treatment? In Historic Move, FDA Considers New Drug Application
December 12, 2023
Tags
Legal
FDA
Government
From
Benzinga
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program
September 25, 2023
Tags
Psychedelics Therapy Training
News
MDMA/assisted therapy
From
Benzinga
Psychedelics Researchers & Industry Leaders Weigh In On Groundbreaking PTSD Treatment News
September 15, 2023
Tickers
NUMIF
Tags
PTSD treatment
MDMA/assisted therapy
Psychedelics
From
Benzinga
Treating PTSD With MDMA Therapy: New Results From MAPS Clinical Study, FDA Submission Next
September 14, 2023
Tags
Psychedelics Reform
Markets
Cannabis
From
Benzinga
Fluence Inks Deal To Bring Brazil's Psychedelic Therapy Training Scene To New Heights
July 26, 2023
Tags
Phaneros Institute
Brazil Psychedelics
Guidance
From
Benzinga
MDMA Deals: Optimi Supplies Numinus-MAPS Program & PharmAla Exports To Australian University
June 20, 2023
Tickers
NUMIF
OPTHF
PMBHF
Tags
MDMA/assisted therapy
Psychedelics
Benzinga
From
Benzinga
Numinus Partners With MAPS To Conduct Phase 1 MDMA Assisted Therapy Investigational Study
June 16, 2023
Tickers
MAPS
NUMIF
Tags
Government
Psychedelics
Benzinga
From
Benzinga
Promising Milestone: FDA Approves California-Based Trial Assessing MDMA For Schizophrenia
June 12, 2023
Tickers
PMBHF
Tags
Guidance
News
Penny Stocks
From
Benzinga
Creso Pharma's LOI For Import Of Swiss MDMA And Psilocybin Therapeutics To Australia
June 09, 2023
Tickers
COPHF
MNMD
Tags
News
Penny Stocks
Global
From
Benzinga
EXCLUSIVE: MDMA Therapy Experts Debate Upcoming Approval And Psychedelic Market Opps
April 19, 2023
Tickers
AWKNF
Tags
News
Exclusives
Robert Velarde
From
Benzinga
Two Psychedelics Companies Collaborate To Provide Clinical-Grade MDMA Capsules For Authorized Patients And Studies
April 11, 2023
Tickers
FLHLF
Tags
PharmAla Biotech Holdings Inc
Management
Psychedelics
From
Benzinga
MDMA Transdermal Patch Moves Toward First-In-Human Trials: Latest Development Update
April 03, 2023
Tickers
PHRRF
RVVTF
Tags
Australia Psychedelics
PHRRF
Benzinga
From
Benzinga
MDMA News: Exclusive Supply Deal With Awakn Life Sciences & Canadian Company Expands Psychedelics Production
March 02, 2023
Tickers
AWKNF
Tags
Controlled Substances Act
Market News
Cannabis
From
Benzinga
Australia's Psychedelics Therapy Provides Hope For Treatment-Resistant Mental Health Conditions
February 07, 2023
Tickers
NUMIF
Tags
Market News
Cannabis
Markets
From
Benzinga
Psyched: Australia Legalizes Psychedelics Therapy, BC's Decrim, State Bills, Millions For Trials & Clinics
February 06, 2023
Tickers
IWINF
ORIG
PHRRF
PSIL
Tags
Benzinga
Psychedelics
MDMA/assisted therapy
From
Benzinga
MDMA News: Optimi's New Drug Now Available, Revive Advances Transdermal Patch Evaluations
February 06, 2023
Tickers
OPTHF
PHRRF
RVVTF
Tags
Psychedelics Investing
PHRRF
Health Canada Special Access Program
From
Benzinga
MDMA Therapy For Chronic PTSD: Neuroimaging With Veterans & First Responders Provides Further Evidence
January 23, 2023
Tags
News
Veterans
Psychedelics
From
Benzinga
Psyched: NY Discusses Regulations, MDMA For PTSD Aims For Legalization, Shrooms For Eating Disorders & More
January 10, 2023
Tickers
PSIL
PSYK
TRYPF
Tags
Psychedelics
MDMA/assisted therapy
Benzinga
From
Benzinga
Is Psychedelic Treatment Around The Corner? MDMA For PTSD Checks Positive In MAPS' 2nd Phase 3 Trial
January 05, 2023
Tags
Markets
Cannabis
Market News
From
Benzinga
Psyched: Musk's Empathy Tweets, Psychedelics In Congress, Oregon's Opt-Outs, MAPS' MDMA Trial And More
November 21, 2022
Tickers
AGNPF
BMNDF
CMND
CMPS
Tags
Benzinga
BMNDF
KONEF
From
Benzinga
MAPS Completes Second Phase 3 Trial Of MDMA-Assisted Therapy For PTSD, Topline Data & New Drug Application Next
November 17, 2022
Tags
Cannabis
Market News
Markets
From
Benzinga
Atai's New MDMA-Based EMP-01 Compound Moves Forward To The Clinical Stage
September 27, 2022
Tickers
ATAI
Tags
Glenn Short
Psychedelics
MDMA/assisted therapy
From
Benzinga
Awakn Shares Its Q2 2022 Results, Showing Consistent Growth On Its Second Full Financial Year
September 17, 2022
Tickers
AWKNF
Tags
Penny Stocks
Earnings
Anthony Tennyson
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.